These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34277801)

  • 1. Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer.
    Chen J; Deng S; Zhang Y; Wang C; Hu X; Kong D; Liang G; Yuan X; Li Y; Wang X
    Ann Transl Med; 2021 Jun; 9(12):1001. PubMed ID: 34277801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer.
    Li J; Zhang D; Liu Z; Wang Y; Li X; Wang Z; Liang G; Yuan X; Li Y; Komorowski AL; Rozen WM; Orlandi A; Takabe K; Franceschini G; Jerusalem G; Wang X
    Ann Transl Med; 2023 Jan; 11(2):83. PubMed ID: 36819490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
    Gao Z; Shi M; Wang Y; Chen J; Ou Y
    Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
    Li G; Xu D; Sun J; Zhao S; Zheng D
    Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway.
    Bei Y; Chen X; Xu Q; Lv J; Hu J; Yang S
    Drug Dev Res; 2022 Apr; 83(2):379-388. PubMed ID: 34405891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic anticancer mechanisms of curcumol and paclitaxel in triple-negative breast cancer treatment may involve down-regulating ZBTB7A expression via the NF-B signaling pathway.
    Mao A; Qin Q; Yang W; Wei C
    Iran J Basic Med Sci; 2022 May; 25(5):652-658. PubMed ID: 35911648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
    Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
    J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways.
    Wang P; Song D; Wan D; Li L; Mei W; Li X; Han L; Zhu X; Yang L; Cai Y; Zhang R
    PeerJ; 2020; 8():e9281. PubMed ID: 32547883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest.
    Wang Y; Wu N; Zhang J; Wang H; Men X
    Onco Targets Ther; 2020; 13():4089-4097. PubMed ID: 32494162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Anti-Tumor Effect of Toosendanin and Paclitaxel on Triple-Negative Breast Cancer via Regulating ADORA2A-EMT Related Signaling.
    Zhang J; Xu HX; Wu YL; Cho WCS; Xian YF; Lin ZX
    Adv Biol (Weinh); 2023 Aug; 7(8):e2300062. PubMed ID: 37401656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
    Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective suppression of triple negative breast cancer by paclitaxel nanoparticles conjugated with transmembrane TNF-α monoclonal antibody.
    Liu J; Wang P; Huang B; Cheng Q; Duan Y; Chen L; Ma T; Zhu C; Li D; Fan W; Yu M
    Int J Pharm; 2022 Aug; 624():121969. PubMed ID: 35803533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage.
    Haynes BM; Cunningham K; Shekhar MPV
    BMC Cancer; 2022 Oct; 22(1):1073. PubMed ID: 36258187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis.
    Zhao PW; Cui JX; Wang XM
    Pharmacogenomics J; 2024 Feb; 24(2):5. PubMed ID: 38378770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
    Huang M; Huang B; Li G; Zeng S
    BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
    Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
    [No Abstract]   [Full Text] [Related]  

  • 20. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
    Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
    Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.